Clinical Trials Directory

Trials / No Longer Available

No Longer AvailableNCT00604643

Talent Aortic Cuff Stent Graft System Compassionate Use Registry

Compassionate Use of the TALENT Aortic Cuff in the Treatment of Patients Previously Treated With the AneuRx Stent Graft System With Sub-Optimal Stent Graft Outcomes

Status
No Longer Available
Phase
Study type
Expanded Access
Enrollment
Sponsor
Medtronic Cardiovascular · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

An evaluation of the TALENT Aortic Cuff in patients with existing AneuRx stent grafts who have experienced sub-optimal stent graft outcomes and are not deemed suitable candidates for treatment with an AneuRx Aortic Cuff.

Detailed description

The primary purpose of this registry is to provide an endovascular means of treatment for those patients experiencing a sub-optimal outcome related to the implanted AneuRx bifurcated stent graft and who are not deemed suitable candidates for treatment with an AneuRx Aortic Cuff. A sub-optimal outcome is defined as either a Type I or Type III endoleak and/or an inadequate seal zone (\< 1 cm). For Registry purposes, a Type III endoleak will be defined as a proximal modular endoleak.

Conditions

Interventions

TypeNameDescription
DEVICETALENT Aortic Cuff Abdominal Stent GraftEndovascular Aneurysm Repair

Timeline

First posted
2008-01-30
Last updated
2021-11-02

Locations

50 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00604643. Inclusion in this directory is not an endorsement.

Talent Aortic Cuff Stent Graft System Compassionate Use Registry (NCT00604643) · Clinical Trials Directory